drug

inotuzumab ozogamicin

2 stories · latest Nov 6, 2026

Timeline

FDA approves Besponsa for pediatric ALL patients

Nov 6Regulatory decisioninotuzumab ozogamicin Pfizer

BeOne registers pediatric trial of sonrotoclax in relapsed AML and B-cell ALL

Aug 18Trial updateBeiGene sonrotoclax